AT A GLANCE COMMENTARY Scientific Knowledge on the Subject
Chlamydia pneumoniae (Cpn) infection may play a role in the pathogenesis of chronic obstructive pulmonary disease. Few data are available comparing persistent and acute infection of this pathogen in the human respiratory tract.
What This Study Adds to the Field
Although acute infection with Cpn elicited an inflammatory response via Toll-like receptor 2, chronic infection in patients with chronic obstructive pulmonary disease was not associated with enhanced lung pathology, suggesting different roles of Cpn. pulmonary disease (COPD) (2) (3) (4) . Highly different Cpn infection rates in patients with COPD have been reported, ranging from 4 to 34% during exacerbations (3, 5, 6 ) and 24 to 38% in exacerbation-free intervals (7, 8) . This may be due to differences in study populations, epidemiologic variation, and the limitations of the main diagnostic techniques, such as serology (which is inaccurate in distinguishing acute and chronic infection) and polymerase chain reaction (PCR) (which lacks international standardization). Interestingly, chronic chlamydial infection in patients with stable COPD was observed to be related to a higher rate of exacerbations (9) , which is in line with the link between bacterial colonization and chronic airway inflammation and the decline of lung function described in recent years (10, 11) . In contrast, Seemungal and colleagues did not find an association between Cpn detection in the airways at exacerbations and exacerbation frequency (8) . Thus, the possible role of Cpn in the pathogenesis of COPD remains controversial, and the consequences of chronic tissue infection with Cpn are not clear.
Few data are available concerning the presence of Cpn in human lung tissue. Wu and associates reported immunohistochemical detection of Cpn in 54% of alveolar macrophages (AMs) from patients with COPD and in 29% of cells from control subjects (12) . We recently have detected Cpn in 13% of COPD lung tissue by in situ hybridization (ISH) (13) . Regarding the consequences of acute chlamydial infection, we and other groups have shown that AMs respond to Cpn infection in vitro with a strong release of inflammatory mediators (14, 15) .
Toll-like receptors (TLRs) are central molecules for the recognition of pathogens and the induction of inflammation (16) . TLR2 responds preferentially to components of gram-positive bacteria, such as peptidoglycan and lipoteichoic acid (16) , whereas TLR4 responds to components of gram-negative bacteria, such as lipopolysaccharide (LPS) (17) . Interestingly, TLR2 has been described to predominantly interact with Cpn in vitro (18, 19) . TLR2 is expressed on AMs and alveolar epithelial cells (AECs) (20) . We recently described an altered AM phenotype of patients with COPD and smokers with reduced TLR2 expression compared with nonsmokers (21) . Thus, patients with COPD may be more susceptible to Cpn infection due to impaired pathogen recognition. TLR4 is functionally expressed on AECs (22) and may also play a role in Chlamydia-induced immune responses (23) .
The aim of the present study was to comparatively evaluate the role of Cpn during chronic infection in patients with stable COPD and in an acute human lung tissue infection model. Nuclear factor (NF)-B and CXC chemokine ligand (CXCL)-8 were chosen as markers of early cellular activation and innate response because they are critical components of the airway inflammation associated with COPD. In addition, the role of TLR2 or TLR4 in pathogen-induced innate responses was evaluated.
Some of the results of this study have been previously reported in abstract form (24) .
METHODS

Study Protocol
Cpn-induced innate immune responses in lung tissues obtained from patients with COPD and control subjects were studied ex vivo and in vitro. Detection of Cpn was done ex vivo in unstimulated tissue using nested PCR, ISH, and immunohistochemistry (IHC), and in vitro by using an acute Chlamydia infection model (ACIM). For the assessment of early cellular responses, NF-B activation using electrophoretic mobility shift assay and CXCL-8 expression using enzyme-linked immunosorbent assay (ELISA) and ISH were evaluated. The role of TLR2 and TLR4 in Cpn-induced innate responses was tested by blocking experiments with monoclonal antibodies.
Lung Tissues
The specimens were tumor-free material at least 5 cm away from the tumor front. For in vitro infection experiments, lung specimens (1 cm 3 ) were cultured in RPMI 1640 medium (Sigma, Taufkirchen, Germany) at 37ЊC and 5% CO 2 for 24 hours and incubated with 500 l chlamydial suspensions (10 7 inclusion-forming units per one milliliter [IFU/ml]) as described previously (13) . Tissues were fixed using the HOPE (HEPESglutamic acid buffer mediated organic solvent protection effect) technique (25) . See the online supplement for additional details.
Culture of Cpn
The respiratory isolate Cpn CWL029 (American Type Culture Collection [ATCC] VR-1310) was grown on HEp-2 monolayers as described previously (26) .
ISH
Hybridization targeting the Cpn-specific PstI fragment and a 272-bp fragment of human CXCL-8 mRNA was performed overnight in moist chambers at 46ЊC (27) . All samples were analyzed by two independent investigators (T.G. and D.D.). See the online supplement for additional details.
Real-Time Reverse Transcriptase-PCR of TLR2 and TLR4 mRNA Expression
Reverse transcriptase (RT)-PCR was performed using the NucleoSpin RNA II kit (Macherey-Nagel, Dueren, Germany) and reverse transcribed into complementary DNA (Roche First-Strand PCR kit; Roche Diagnostics, Mannheim, Germany), PCR amplification was performed using the LightCycler Detection System (Roche Molecular Biochemicals, Mannheim, Germany).
Immunohistochemical Staining
Primary antibodies (anti-human TLR2, clone TL2.1; kindly provided by Genentech, San Francisco, CA; anti-human TLR2, clone TL2.1, antihuman TLR4; eBioscience, San Diego, CA; anti-NF-B p65 subunit; Chemicon International, Temecula, CA; antichlamydial LPS, CF-2; Washington Research Foundation, WA; and major outer membrane protein, clone RR402; Dako, Glostrup, Denmark) were applied in a dilution of 1:100 as described elsewhere (20) .
NF-B Activation by Electrophoretic Mobility Shift Assay
Preparation of nuclear extracts was done as described elsewhere (28) . Oligonucleotides containing the NF-B consensus sequence element were obtained from Geneka Biotech, Inc. (Montreal, PQ, Canada).
Cell Culture
A549 cells obtained from the European collection of cell cultures were grown in 25 cm 2 polystyrene flasks with Dulbecco's modified Eagle's medium (Sigma). Cells were seeded in 35-mm tissue culture dishes (Nunc, Weisbaden, Germany). A549 cells were preincubated (1 h, 37ЊC) with TLR2 and TLR4 monoclonal antibodies (1 g/ml) before stimulation with Cpn. Analogous lung specimens were preincubated before stimulation with Cpn and cultured.
Cytokine Assays
Measurement of CXCL-8 levels in supernatants was performed using commercially available ELISA kits (Biosource, Solingen, Germany).
Statistical Analysis
Data are presented as the mean Ϯ SD. Statistics were performed with nonparametric tests. For independent samples, Student's t test was used. For categorical variables, 2ϫ2 tables were analyzed using a chi-square test. p values less than 0.05 were considered statistically significant. Calculations were performed with Statistica for Windows (version 5; Statsoft, Hamburg, Germany), 1997.
RESULTS
Patients and Lung Tissues
The study population consisted of 42 patients with COPD (mean age, 62 yr; 29 males, 13 females; mean pack-years, 59; GOLD [Global Initiative for Chronic Obstructive Lung Disease] stage I: 4 patients, stage II: 23 patients, stage III: 15 patients) who had an indication for lung surgery of peripheral nodules (Table 1) . No patient had undergone antimicrobial treatment before the operation. Systemic steroid treatment was administered preoperatively in 13 of 42 patients in doses of less than 20 mg/day of prednisone equivalent. Nevertheless, we found no differences of NF-B and CXCL-8 expression between patients with COPD treated and not treated with steroids (data not shown). Eleven patients without chronic airway diseases served as control subjects (mean age, 59 yr; 6 males, 5 females). Lung tissue samples were obtained from lobectomy or atypical resections (patients with COPD, n ϭ 42: lung cancer, n ϭ 35; metastases of extrapulmonary tumors, n ϭ 5; benign nodules, n ϭ 2; control subjects, n ϭ 11: lung cancer, n ϭ 2; metastases of extrapulmonary tumors, n ϭ 7; benign nodules, n ϭ 2).
Detection of Cpn Infection in Lung Tissue Ex Vivo
Fifteen percent (n ϭ 6 of 42) of the COPD lung tissue proved to be Cpn-DNA positive as detected by nested PCR. In all Cpnpositive lungs, PCR detection was confirmed by positive signals using ISH targeting chlamydial DNA and IHC for major outer membrane proteins and chlamydial LPS. Cpn-DNA-negative lungs did not show positive signals using ISH and IHC for chlamydial LPS.
Representative findings in COPD lung tissue are displayed in Figure 1 . Chlamydial infection was primarily detected in AMs Definition of abbreviations: COPD ϭ chronic obstructive pulmonary disease; Cpn ϭ C. pneumoniae; GOLD ϭ Global Initiative for Chronic Obstructive Lung Disease; IHC ϭ immunohistochemistry; PCR ϭ polymerase chain reaction.
* p Ͻ 0.05 compared to controls (chi-square).
( Figures 1A, 1C , and 1D) and to a lesser degree also in AECs ( Figure 1B ). There was no difference regarding infection rates between tissue from patients with early (GOLD I/II) or late (GOLD III) stage COPD. The distribution of Cpn-positive cells in the lung tissue showed a nonhomogeneous, patchy pattern.
In lung tissues of patients without COPD, there was no detection of Cpn using PCR (p Ͻ 0.05, Table 1 ).
Pathogen-induced Cellular Activation and Immune Response in Acute and Chronic Chlamydial Infection
Histologic assessment of lung tissue by investigators blinded to the results of Cpn detection did not reveal increased inflammation levels in lungs with persistent Cpn infection ( Figure 1E ). To evaluate more specifically whether Cpn detection is associated with increased cellular activation, NF-B translocation was concomitantly assessed in adjacent tissue sections because NF-B activation is known to be an important step in Cpninduced innate responses. Figure 2A shows that NF-B is upregulated in COPD lungs as compared with control lungs without an underlying pulmonary condition. However, no difference in NF-B expression between patients with COPD and those without Cpn detection ex vivo was observed. In contrast, after Cpn in vitro infection using the ACIM, a marked cellular activation indicated by NF-B translocation was consistently found. The infection pattern in the ACIM showed primarily infection of AMs ( Figure 3A) , and positive signals for the NF-B p65 subunit expression were demonstrated in these cells ( Figure 3B ). In addition, the expression of CXCL-8 as an important early innate response mediator was evaluated in both models. Again, enhanced unstimulated expression was seen in patients with COPD compared with control subjects, but there was no increase in the Cpn-positive lungs ex vivo. In contrast, marked increase of CXCL-8 expression was found in the ACIM ( Figure 2B ).
TLR Expression in Cpn-infected Lung Tissue
Comparing TLR2 and TLR4 protein expression (IHC) in COPD lung tissue, we found a strong expression of TLR2 in contrast to TLR4 ex vivo (Figure 4 ). TLR2 expression was seen in AMs and AECs, whereas TLR4 expression was demonstrable mainly in AMs and rarely in alveolar epithelia. Cpn infection detected ex vivo did not influence TLR2 and TLR4 expression (data not shown). Comparing detection of TLR2 and TLR4 mRNA, there were again no differences according to Cpn infection status. In contrast, in the in vitro infection model, we found a marked upregulation of TLR2 but not TLR4 after incubation with Cpn. Data are shown for TLR2 ( Figure 4C ).
Modulation of TLR Expression
Cell culture and tissue experiments using a human alveolar type II epithelium-like cell line (A549) and the ACIM revealed that inhibition of TLR2 signaling by a neutralizing antibody results in a significantly reduced innate response to Cpn infection as evidenced by CXCL-8 release from cell and tissue culture (shown for tissue culture, Figure 4D ). In contrast, blocking of TLR4 had no effect. In contrast to the effects on the immune response, TLR blockade had no influence on infection rates in the tissue model (Table 2) .
DISCUSSION
In the present study, we demonstrate that chronic Cpn infection is detected in 15% of lungs from patients with COPD but is not associated with enhanced host cell activation. This is in contrast to acute Cpn in vitro infection of lung tissue, which elicits a marked innate immune response dependent on TLR2-but not TLR4-signaling. In lung tissue of patients without COPD, Cpn infection was not detected. Detection of Cpn in respiratory tissue has previously been reported by Wu and colleagues who described the localization of Chlamydia in AMs using IHC, and found that all tested lungs from patients with and without COPD were Cpn positive in contrast to PCR results. The immunohistochemical staining was more intense in lung tissue from patients with COPD (12) . We confirmed the increased detection of Cpn in COPD as compared with control patients, but observed chlamydial infection in a clearly lower proportion of patients than did Wu and colleagues, which may be due to differences in the experimental protocols. The specificity of our detection methods is underlined by the fact that positive results obtained in the PCR were all confirmed in the ISH and IHC procedures. There was no association of Cpn detection to COPD stage and lung function, which is in line with data from serological profiles and PCR in peripheral blood mononuclear cells (29, 30) . A trigger role of Cpn infection in chronic airway inflammation is suggested by the marked proinflammatory response elicited by this microorganism in vitro (15, 31) and by the antiapoptotic effect of chlamydial infection on immune cells (32, 33) . In the ACIM, we demonstrated an increased CXCL-8 release after Cpn infection and the expression of the p65 subunit mainly in AMs, indicating the activated form of NF-B. This is in line with previous data from cell culture experiments in endothelial cells infected with Cpn (34) as well as in human airway epithelial cells (35) . Krull and colleagues demonstrated the activation of different signal transduction pathways such as protein tyrosine phosphorylation and up-regulation of phosphorylated p42/p44 mitogen-activated protein kinase. In addition, enhanced expression of endothelial adhesion molecules was shown (32) . Interaction among different lung cells may play an additional role because coincubation of leukocytes with AECs facilitates the infection of epithelial cells (36) .
What are the implications of these findings for chronic chlamydial lung infection in vivo? Detection of Cpn in lung tissue from patients with COPD was not associated with enhanced cellular activation in our study as evaluated by conventional histology, NF-B expression, and CXCL-8 expression. These findings suggest that detection of this pathogen in human lung tissue is not necessarily associated with an active immune response. This has also been experienced in cardiovascular diseases where frequent demonstration of Cpn in atherosclerotic plaques was not consistently associated with disease. Moreover, large intervention trials with antimicrobial agents active against chlamydiae have not shown significant benefits (37) . Regarding respiratory disease, a recent trial of ketolide treatment in patients with asthma found a significant reduction of asthma symptoms in the verum group, but no relationship between chlamydia or mycoplasma infection status and the response to treatment (38) .
The discrepancies between the acute in vitro infection model and the ex vivo findings may be due to the difference between acute and persistent Cpn infection. Persistence is a well-known phenomenon of chlamydial infection. It is facilitated by the intracellular life cycle of this microorganism and may explain a reduced inflammatory potential in vivo. Subinhibitory concentrations of antibiotics, cytokine treatment, induction of the tryptophandegrading enzyme indoleamine 2,3-dioxygenase, and iron depletion have been reported to induce chlamydial persistence in epithelial cell cultures (39) (40) (41) . In addition, an incomplete developmental cycle and restricted growth of Cpn have been described in AMs (14) . Although distinct morphologic characteristics, like a decrease in typical inclusions and an increase of smaller, less dense atypical inclusions, are observed in these models, transcriptome and proteome analyses are not as consistent. Several alterations in pathogen and host genes, such as chlamydial major outer membrane protein, the cysteine-rich outer membrane protein omcB, and chlamydial heat shock protein-60 (14, 42, 43), have been described in persistence models, but none of them has been attributed so far to the state of chlamydial infection found in chronic airway diseases. A higher rate of acute exacerbations in patients with chronic bronchitis with Cpn colonization (determined by Cpn-DNA detection) is one of the few clinical markers to show an association with long-term Cpn infection (9) . Physiologic or pharmacologic mediators influencing the switch between the acute and the persistent phase of chlamydial infection in vivo are unknown, but could be of interest to better understand the host-pathogen interaction and to modulate persistent chlamydial infections.
Regarding the role of TLRs for the recognition of chlamydia and induction of the innate response, the majority of data describe a predominant role of TLR2. Netea and colleagues demonstrated that stimulation of proinflammatory cytokines by Cpn in human mononuclear cells is a TLR2-dependent event and TLR4 as well as CD14 do not play important roles in this process (18) . Prebeck showed similar results indicating a predominant role of TLR2 for detection of Cpn in dendritic cells in contrast to TLR4 (19) . In addition, TLR-independent, but MyD88-dependent signaling with stimulation of IL-18 has recently been demonstrated (44) . The expression of TLR2 in human lung was recently characterized by our group not only in AMs but also in AECs, which are involved in the immune response to Cpn (20) . Our results from in vitro-infected lung tissue suggest a prominent role of TLR2 in the innate response to Cpn with markedly diminished IL-8 release after selective receptor blockade. Considering the altered phenotype of AMs from patients with COPD and smokers (21) with decreased TLR2 expression, this may explain the increased susceptibility of these persons to Cpn infection (5) . On the other hand, recent data suggest that Cpn infection is associated with an unbalanced proinflammatory cytokine response in patients with COPD as compared with healthy control subjects (31) . The combination of impaired host defense and enhanced cytokine response could contribute to the development of chronic airway inflammation in COPD. TLR4 has also been implicated in Cpn-induced cell activation (23, 45) and has been shown to be functional when expressed on AECs (22) . However, we could only demonstrate a very weak expression of TLR4 protein in human lung tissue and no effect of TLR4 blockade in the context of Cpn infection.
Surprisingly, there was no concomitant effect of anti-TLR2 treatment on chlamydial infection rates. The dissociation between effects on the immune response and on bacterial clearance also has been observed recently in knockout models after chlamydial infection (23) as well as in pneumococcal disease (46) . The reasons for this phenomenon are not clear. Possible explanations include TLR-independent defense mechanisms, multicomponent receptor clusters, which may partly compensate for blockade of single components, and interactions between cytokine concentrations and bacterial metabolism (47) . Further studies are needed to elucidate the role of these mechanisms in the interplay of inflammation and bacterial growth.
In conclusion, our findings suggest that chronic Cpn infection is frequent in patients with COPD. Pathogen recognition in acute infection is mainly mediated by TLR2, leading to a marked innate immune response in vitro. However, detection of Cpn from clinical samples is not associated with enhanced lung cell activation and may solely indicate persistence. Further studies are needed to clarify which environmental or pathogen-induced factors are responsible for the initiation of productive chlamydial infection.
